Cargando…
Protective Effect of Asacol in Combination with Pantoprazole in Ulcerative Colitis Patients Who Defecate Asacol Tablets Intactly: A Clinical Trial Study
PURPOSE: Mesalazine formulations are the drug of choice in the treatment of ulcerative colitis (UC). They are released at alkaline pH in order to deliver 5-aminosalicylic acid to the colon. The colonic pH is significantly lower in UC patients than in normal patients. This study was conducted for the...
Autores principales: | Bashiri, Homayoon, Bozorgomid, Arezoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986402/ https://www.ncbi.nlm.nih.gov/pubmed/32158250 http://dx.doi.org/10.2147/CEG.S225675 |
Ejemplares similares
-
Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study
por: Park, Soo-Kyung, et al.
Publicado: (2019) -
2.4 g Mesalamine (Asacol 400 mg tablet) Once Daily is as Effective as Three Times Daily in Maintenance of Remission in Ulcerative Colitis: A Randomized, Noninferiority, Multi-center Trial
por: Suzuki, Yasuo, et al.
Publicado: (2017) -
One-year Investigator-blind Randomized Multicenter Trial Comparing Asacol 2.4 g Once Daily with 800 mg Three Times Daily for Maintenance of Remission in Ulcerative Colitis
por: Hawthorne, A Barney, et al.
Publicado: (2012) -
Efficacy of Hijamat (wet cupping therapy) in Iranian patients with nonalcoholic fatty liver disease: a controlled clinical trial
por: BASHIRI, Homayoon, et al.
Publicado: (2020) -
Biliary of Fascioliasis in Kermanshah Province, Western Iran
por: BASHIRI, Homayoon, et al.
Publicado: (2021)